Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China

被引:1
作者
Xie, Shilan [1 ]
Yan, Jin [2 ]
Fu, Xiaobing [1 ]
Yu, Guolong [2 ]
Yan, Xinge [2 ]
Yang, Fang [1 ]
Li, Bosheng [2 ]
机构
[1] Inst HIV AIDS Prevent, Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Guangdong, Peoples R China
[2] Guangdong Prov Ctr Dis Control & Prevent, Inst Pathogen Microorg, RM 2528,160 Qunxian Rd, Guangzhou 511430, Guangdong, Peoples R China
关键词
Hepatitis C virus; Subtype; NS5A; Resistance-associated substitution; Guangdong; GENOTYPE; 6; ANTIVIRAL DRUGS; HCV INFECTION; PREVALENCE; TRANSMISSION; PATTERNS; NS5A; NS3;
D O I
10.1016/j.meegid.2024.105653
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: In Guangdong Province, hepatitis C virus (HCV) had been found to confer resistance to direct-acting antivirals (DAAs). There were few studies of HCV subtypes and resistance-associated substitutions (RASs) of HCV in different high-risk populations. In this study, we aimed to determine the subtype distribution and the RASs in high-risk population groups, including drug users (DU), men who have sex with men (MSM), female sex workers (FSW), and male patients with sexually transmitted diseases (STD) in Guangdong Province (a highly developed province with a large population). Methods: Using a city-based sampling strategy,1356 samples were obtained from different population groups. Phylogenetic analyses determined subtypes based on Core, NS5B, or NS5A sequences. HCV subtype distribution and RASs in various risk groups and regions were analyzed. Results: Ten subtypes, of which 6 h and 6 k were novel in Guangdong, were identified. The primary subtype among all risk groups was 6a. RASs in 1b and 3a were different from those observed in other studies. Subtype 3b in western Guangdong was higher than the other three regions. No RASs were found in 6a or any other genotype 6. Conclusions: The HCV subtypes are expanding in high-risk populations in Guangdong. Drug use by other risk groups and commercial sex by DU may bridge the dissemination of 6a from DU to other populations. The RAS profiles of 1b and 3a differed from those reported in studies conducted in southwestern China. Further research is required to determine the reason for this discrepancy. Moreover, the combination of RASs was high in subtype 3b. To guide HCV treatment of subtype 3b, pretreatment subtyping of HCV genotype 3 should be considered in western cities in the near future.
引用
收藏
页数:8
相关论文
共 50 条
[21]   NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome [J].
Zeuzem, Stefan ;
Mizokami, Masashi ;
Pianko, Stephen ;
Mangia, Alessandra ;
Han, Kwang-Hyub ;
Martin, Ross ;
Svarovskaia, Evguenia ;
Dvory-Sobol, Hadas ;
Doehle, Brian ;
Hedskog, Charlotte ;
Yun, Chohee ;
Brainard, Diana M. ;
Knox, Steven ;
McHutchison, John G. ;
Miller, Michael D. ;
Mo, Hongmei ;
Chuang, Wan-Long ;
Jacobson, Ira ;
Dore, Gregory J. ;
Sulkowski, Mark .
JOURNAL OF HEPATOLOGY, 2017, 66 (05) :910-918
[22]   Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon [J].
Ndjomou, J ;
Kupfer, B ;
Kochan, B ;
Zekeng, L ;
Kaptue, L ;
Matz, B .
JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (02) :179-186
[23]   Seroprevalence, Risk Factors, and Hepatitis C Virus Genotypes in Groups With High-Risk Sexual Behavior in Croatia [J].
Cavlek, Tatjana Vilibic ;
Margan, Ira Gjenero ;
Lepej, Snjezana Zidovec ;
Kolaric, Branko ;
Vince, Adriana .
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (08) :1348-1353
[24]   High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection [J].
von Felden, J. ;
Vermehren, J. ;
Ingiliz, P. ;
Mauss, S. ;
Lutz, T. ;
Simon, K. G. ;
Busch, H. W. ;
Baumgarten, A. ;
Schewe, K. ;
Hueppe, D. ;
Boesecke, C. ;
Rockstroh, J. K. ;
Daeumer, M. ;
Luebke, N. ;
Timm, J. ;
zur Wiesch, J. Schulze ;
Sarrazin, C. ;
Christensen, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) :1288-1295
[25]   Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant [J].
Perales, Celia ;
Chen, Qian ;
Eugenia Soria, Maria ;
Gregori, Josep ;
Garcia-Cehic, Damir ;
Nieto-Aponte, Leonardo ;
Castells, Lluis ;
Imaz, Arkaitz ;
Llorens-Revull, Meritxell ;
Domingo, Esteban ;
Buti, Maria ;
Ignacio Esteban, Juan ;
Rodriguez-Frias, Francisco ;
Quer, Josep .
INFECTION AND DRUG RESISTANCE, 2018, 11 :2207-2210
[26]   Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients [J].
Kurniawan, Juferdy ;
Handayu, Anugrah Dwi ;
Aprilicia, Gita ;
Bahri, Darlene Raudhatul ;
Hasan, Irsan .
ACTA MEDICA INDONESIANA, 2024, 56 (04) :451-460
[27]   Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C [J].
Ahmed, Hala Rady ;
Waly, Nancy G. F. M. ;
Abd El-Baky, Rehab Mahmoud ;
Yahia, Ramadan ;
Hetta, Helal F. ;
Elsayed, Amr M. ;
Ibrahem, Reham Ali .
PLOS ONE, 2021, 16 (04)
[28]   Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province [J].
Wang, Min ;
Liao, Qiao ;
Xu, Ru ;
Song, Dandan ;
Huang, Jieting ;
You, Qingzhu ;
Shan, Zhengang ;
Huang, Ke ;
Rong, Xia ;
Fu, Yongshui .
ARCHIVES OF VIROLOGY, 2019, 164 (07) :1761-1770
[29]   Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea [J].
Kim, Kyung-Ah ;
Lee, Sejoon ;
Park, Hye Jung ;
Jang, Eun Sun ;
Lee, Youn Jae ;
Cho, Sung Bum ;
Kim, Young Suk ;
Kim, In Hee ;
Lee, Byung Seok ;
Chung, Woo Jin ;
Ahn, Sang Hoon ;
Kim, Seungtaek ;
Jeong, Sook Hyang .
CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) :496-509
[30]   Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection [J].
Rahimi, Pooneh ;
Sharafi, Heidar ;
Bahramali, Golnaz ;
SajadianFard, FaridehSadat ;
Asadi, Nafiseh Sadat ;
Alavian, Seyed Moayed ;
Mobarakeh, Vahid Iranpur ;
Moravej, Seyedeh Zahra .
FRONTIERS IN MICROBIOLOGY, 2021, 11